Health TrialsbyHealthPanel

Evaluating the Effect of the Automatic Surveillance System on Surveillance Rate of Colorectal Postpolypectomy Patients

ConditionsArtificial IntelligenceSurveillance
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorRenmin Hospital of Wuhan University

About this trial

In this study, we proposed a prospective study about the effect of the automatic surveillance system on surveillance rate of colorectal postpolypectomy patients. The enrolled patients were divided into group A with intelligent surveillance system, group B with manual reminder, and group C with natural state. The surveillance among the three groups were compared.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Male or female aged 18 years or older who undergo colonoscopy.

Disqualifiers

1)No pathological result.

2) No or invalid contact information.

3) The surveillance interval cannot be determined according to the surveillance guidelines, including poor bowel preparation, colorectal cancer or suspicious malignance, surgery or colorectal ESD history, those who fail to complete colonoscopy due to unbearable, pathological indications of not polyps, hamartoma or lymphoma polyps, history of ulcerative colitis, and so on.

4) Has participated in other clinical trials, signed the informed consent form and is in the surveillance period of other clinical trials.

Trial design

Design model

Parallel

Treatments tested in this trial

  • AI based automatic surveillance (AS) system (ENDOANGEL-AS)

    Other intervention

    An automatic surveillance (AS) system to accurately identify post-polypectomy patients, assign surveillance intervals for different risks of patients and proactively follow up with patients at certain times.

  • Manually remind the patients to review.

    Other intervention

    Medical staff remind patients to review by telephone.

Treatment groups

867 Participants
are divided into 3 treatment groups
Group A: With automatic surveillance systemExperimental treatment 1 intervention
Group B: With manual reminderActive comparator 1 intervention
Group C: Normal groupNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

surveillance rate

The numerator is the number of patients with surveillance, and the denominator is the number of all colorectal postpolypectomy patients requiring surveillance.

Time frame
From enrollment to study completion, assessed up to 3 years.

Secondary outcomes

1

Advance Surveillance Rate

The numerator is the number of patients with surveillance in advance, and the denominator is the number of all colorectal postpolypectomy patients requiring surveillance.

Time frame
From enrollment to study completion, assessed up to 3 years.
2

On-time Surveillance Rate

The numerator is the number of patients with on-time surveillance, and the denominator is the number of all colorectal postpolypectomy patients requiring surveillance.

Time frame
From enrollment to study completion, assessed up to 3 years.
3

Delayed Surveillance Rate

The numerator is the number of patients with delayed surveillance, and the denominator is the number of all colorectal postpolypectomy patients requiring surveillance.

Time frame
From enrollment to study completion, assessed up to 3 years.
4

The accuracy of identifing post-polypectomy patients

The numerator is the number of patients correctly identified into post-polypectomy patients, and the denominator is the number of patients undergoing colonoscopy.

Time frame
At the time of enrollment.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Renmin Hospital of Wuhan University

Lead sponsor

Jiangmen Central Hospital

Collaborator

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: